Literature DB >> 2463847

Immunohistochemical analysis of colon carcinomas applying exocrine and neuroendocrine markers.

D Jansson1, V E Gould, G T Gooch, H G Rittenhouse, S S Shin, G L Manderino, J T Tomita, E D Staren.   

Abstract

Eighty colon carcinomas reflecting the histologic spectrum were studied immunohistochemically; their epithelial characteristics had been established by demonstrating cytokeratin polypeptides. Paraffin sections were immunostained with monoclonal antibody (Mab) A-80 that recognizes a mucin-like glycoprotein related to exocrine differentiation. Sequential sections were immunostained with neuroendocrine (NE) differentiation antibodies: NSE, human chromogranin A, serotonin, somatostatin, substance P and VIP. Twenty-one/80 carcinomas immunoreacted exclusively with Mab A-80; these included adenocarcinomas with variably defined glands, colloid, "solid", and linitits plastica carcinomas. Eleven/80 carcinomas immunoreacted only with antibodies to NE markers. Twenty-nine/80 carcinomas of histologically variable patterns expressed both exocrine and NE antigens. A notable group of 19 adenocarcinomas immunostaining with Mab A-870 included a minority NE cell subpopulation. We tentatively conclude that given a limited battery of immunoprobes, colon carcinomas comprise 4 groups: 1) pure exocrine carcinomas, 2) pure NE carcinomas, 3) mixed exocrine and NE carcinomas, and 4) exocrine carcinomas with occasional NE cells. Thus, phenotypically mixed exocrine and NE carcinomas comprise the largest group while the second largest group exhibited exclusively features of exocrine phenotype. Preliminary clinical correlative data indicate that pure NE colon carcinomas behave more aggressively than their exocrine counterparts; moreover, colon carcinomas containing a NE subpopulation, even if small, also seem to behave worse than their counterparts without an NE subpopulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463847     DOI: 10.1111/j.1699-0463.1988.tb00991.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

Review 1.  Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.

Authors:  Britta Kleist; Micaela Poetsch
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

2.  Cross validation of cluster analysis using immunostained multi-tissue tumour block slides.

Authors:  G L Manderino; J C Leicht; J L Mulshine; G T Gooch
Journal:  Br J Cancer Suppl       Date:  1991-06

3.  Large cell neuroendocrine carcinoma of the colon: A rare and aggressive tumor.

Authors:  Michael R Pascarella; David McCloskey; Jenia Jenab-Wolcott; Marc Vala; Marc Rovito; James McHugh
Journal:  J Gastrointest Oncol       Date:  2011-12

4.  Extracellular matrix components induce endocrine differentiation in vitro in NCI-H716 cells.

Authors:  A P de Bruïne; W N Dinjens; E P van der Linden; M M Pijls; P T Moerkerk; F T Bosman
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

5.  The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas.

Authors:  S Ferrero; R Buffa; G Pruneri; A G Siccardi; M Pelagi; A K Lee; G Coggi; S Bosari
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression?

Authors:  V E Gould; K J Bloom; W W Franke; W H Warren; R Moll
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Immunohistochemical expression of the mucin-type glycoprotein A-80 and prognosis in human breast cancer.

Authors:  E T Eriksson; H Schimmelpenning; L E Rutqvist; H Johansson; G U Auer
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.